Evidence map›Paper›PMID 39926503›Full record

ArticleACS omega2025

ProG-SOL: Predicting Protein Solubility Using Protein Embeddings and Dual-Graph Convolutional Networks.

Gen Li, Ning Zhang, Long Fan

Abstract read
In one paragraph

Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Gen LiProduction and R&D Center I of LSS, GenScript (Shanghai) Biotech Co., Ltd., Shanghai 200131, China.ORCID https://orcid.org/0000-0002-6862-5547
Ning ZhangProduction and R&D Center I of LSS, GenScript Biotech Corporation, Nanjing 211122, China.
Long FanProduction and R&D Center I of LSS, GenScript (Shanghai) Biotech Co., Ltd., Shanghai 200131, China.ORCID https://orcid.org/0000-0001-8938-2225

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Solubility is a key biophysical property of proteins and is essential for evaluating the effectiveness of proteins in biochemical engineering. In recent years, the prediction method of protein solubility has received extensive attention in the protein engineering research community. Many methods have been developed to predict protein solubility, but the generalization performance of existing prediction methods on independent test sets must be improved. In addition, solubility prediction methods do not work well when they are used for regression tasks. To address these issues, we developed a new method, ProG-SOL, an innovative sequence-based dual-graph convolutional network that simultaneously exploits the protein pretrained graph and the protein evolutionary graph for assessing solubility. Compared with other methods, ProG-SOL achieves better classification and regression results for different independent test sets at the same time. The model framework of our method may also be used to predict other properties of proteins such as protein function, protein-protein interaction, protein folding, and drug design, which provide broad application prospects in protein engineering.

Identifiers

PMID39926503
PMCPMC11800053

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.